Wiley Blackwell

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Moskowitz
    Moskowitz
  3. Palomba
    Palomba
  4. Salles
    Salles
  5. Zelenetz
    Zelenetz
  6. Yahalom
    Yahalom
  7. Noy
    Noy
  8. Dogan
    Dogan
  9. Hamlin
    Hamlin
  10. Kumar
    Kumar

Groups

  1. Hematologic Malignancies, Division of (435)
  2. Department of Medicine (432)
  3. Center for Hematologic Malignancies (332)
  4. Lymphoma (174)
  5. Survivorship Research (89)
  6. Solid Tumor Oncology Division (87)
  7. Adult Leukemia (75)
  8. GSK Faculty (73)
  9. Hematology-Oncology Fellows (72)
  10. Population Sciences Research Program (72)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (195)
  2. Journal Article (192)
  3. Book Section (18)
  4. Review (10)
  5. Research Letter (9)
  6. Conference Paper (7)
  7. Editorial (3)
  8. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (435)
  2. Department of Medicine (432)
  3. Center for Hematologic Malignancies (332)
  4. Lymphoma (174)
  5. Survivorship Research (89)
  6. Solid Tumor Oncology Division (87)

More Groups

People
  1. Steven Horwitz (55)
  2. David Straus (36)
  3. Alison Moskowitz (31)
  4. Maria Palomba (31)
  5. Gilles Salles (30)
  6. Andrew Zelenetz (29)

More People

Years
  1. 2025 (11)
  2. 2024 (13)
  3. 2023 (69)
  4. 2022 (6)
  5. 2021 (49)
  6. 2020 (15)

More Years

Publications
  1. Hematological Oncology (170)
  2. Cancer (104)
  3. Transplant Infectious Disease (13)
  4. Cancer Medicine (11)
  5. Cancer Consult: Expertise for Clinical Practice (7)
  6. Cancer Science (6)

More Publications

Results (435)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C. S.; Ang, D.; Dogan, S.; Miller, V. A.; Ladanyi, M.; Kris, M. G.; Riely, G. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Augmenting advance care planning in poor prognosis cancer with a video decision aid
    Journal Article

    Volandes, A. E.; Levin, T. T.; Slovin, S.; Carvajal, R. D.; O'Reilly, E. M.; Keohan, M. L.; Theodoulou, M.; Dickler, M.; Gerecitano, J. F.; Morris, M.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Disseminated mycobacterium marinum infection in a hematopoietic stem cell transplant recipient
    Journal Article

    Jacobs, S.; George, A.; Papanicolaou, G. A.; Lacouture, M. E.; Tan, B. H.; Jakubowski, A. A.; Kaltsas, A.
    Transplant Infectious Disease (2012)

    Fulltext@MSK | Save
  • Letter to the editor: Response to letter from Dr. Eroglu and Dr. Unal
    Journal Article

    Straus, D. J.
    Journal of Internal Medicine (2012)

    Fulltext@MSK | Save
  • Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma
    Journal Article

    Barta, S. K.; Lee, J. Y.; Kaplan, L. D.; Noy, A.; Sparano, J. A.
    Cancer (2012)

    Fulltext@MSK | Save
  • Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer
    Journal Article

    Epstein, A. S.; Soff, G. A.; Capanu, M.; Crosbie, C.; Shah, M. A.; Kelsen, D. P.; Denton, B.; Gardos, S.; O'Reilly, E. M.
    Cancer (2012)

    Fulltext@MSK | Save
  • Durable remission with salvage second autotransplants in patients with multiple myeloma
    Journal Article

    Shah, N.; Ahmed, F.; Bashir, Q.; Qureshi, S.; Dinh, Y.; Rondon, G.; Wen, S.; Thall, P.; Khan, H.; Giralt, S.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Cross-platform comparison of platelet enumeration and potential interferences in patients with hematologic malignancies and varying levels of thrombocytopenia
    Meeting Abstract

    Marionneaux, S.; Maslak, P.; Francisco, N.; Chan, V.; Wright, D.
    International Journal of Laboratory Hematology (2012)

    Fulltext@MSK | Save
  • A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid
    Journal Article

    Sharma, M.; Khan, H.; Thall, P. F.; Orlowski, R. Z.; Bassett, R. L. Jr; Shah, N.; Bashir, Q.; Parmar, S.; Wang, M.; Shah, J. J.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: Findings from a large national database
    Journal Article

    Kumar, A.; Vanderplas, A.; LaCasce, A. S.; Rodriguez, M. A.; Crosby, A. L.; Lepisto, E.; Czuczman, M. S.; Nademanee, A.; Niland, J.; Gordon, L. I.; more...
    Cancer (2012)

    Fulltext@MSK | Save